Pharma's Almanac TV
PA TV
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Investment
172 Articles Available
1
8
Can't find what you're looking for? Try our
advanced search
.
Funding
Novavax Announces $1.6 Billion Funding from Operation Warp Speed
PR-M07-20-NI-006
COVID-19 Vaccine Manufacturing
Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate
PR-M07-20-NI-007
CDMO
Positioning a CDMO to Meet Future Needs
PAP-Q2-20-CL-006
Funding
Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech Pipeline of the Future
PR-M06-20-NI-031
Capacity Expansion
Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability
PR-M06-20-NI-029
IPO
Vaxcyte Announces Pricing of Upsized Initial Public Offering
PR-M06-20-NI-018
Funding
SiO2 Materials Science Receives $143 Million Contract from U.S. Government
PR-M06-20-NI-009
Athira Pharma Closes $85 Million Series B Financing
PR-M06-20-NI-007
Investment
Pfizer Establishes New Program to Support Continued Biotechnology Innovation
PR-M06-20-NI-001
Financing
Hillhouse Capital Leads $160M Series B Round in Genor Biopharma
PR-M06-20-NI-003
COVID-19
Labguru Announces $1M Pro-Bono Program for COVID-19 Treatment Developers
PR-M04-20-NI-021
Investment
Governor Cooper Announces Over 460 Jobs in Durham as Eli Lilly and Company Selects North Carolina for Major Pharmaceutical Plant
PR-M01-20-NI-034
Financing
JOINN Biologics Inc. Receives $60 Million Series A Financing
PR-M12-19-NI-036
Funding
Akoya Biosciences Raises $50 Million in New Financing
PR-M12-19-NI-010
Gene Therapy
Ferring and Blackstone Life Sciences Invest Over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients
PR-M11-19-NI-032
Investment
Lilly Announces $400 Million Capital Investment in Manufacturing Facilities in Indianapolis
PR-M11-19-NI-028
Investment
Boehringer Ingelheim Invests Nearly $50 Million to Expand Plant in Puerto Rico
PR-M11-19-NI-014
Cell and Gene Therapy
FUJIFILM Diosynth Biotechnologies Announces $55 Million Investment to Expand Gene Therapy Development Capabilities
PR-M11-19-NI-013
Executive Compensation
Executive Compensation: Essential Factor in Private Equity Transactions
PAP-Q3-19-CL-007
Funding
Sofinnova Partners Raises €333 Million Capital IX Early-Stage Healthcare Fund
PR-M10-19-NI-027
Investment
PCI Strengthens Position in Europe with Investment in Ireland
PR-M09-19-NI-016
Investment
Rumors Suggest Amgen is Interested in Alexion
PAO-M00-19-NI-001
Investment
Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina
PR-M08-19-NI-079
Financing
Juvenescence Completes $100 Million Series B Financing Round
PAO-M08-19-NI-035
1
8
»
